Fate Therapeutics In
FATE
Delayed Nasdaq - 02/22 07:23:53 pm
10.7965USD
+1.95%
Upcoming events

- No events available -

Past Events
02/15/18 | 03:30pmLEERINK Partners Global Healthcare Conference
12/11/17American Society of Hematology Meeting
11/28/17 | 06:50pmPiper Jaffray Health Care Conference
11/01/17 | 10:00pmQ3 2017 Earnings Call
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
4,40
4,34
1,5%

4,03
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-32,0
-33,4
4,4%

-40,8
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-33,5
-35,0
4,5%

-41,6
Net income
Million $
Released
Forecast
Spread
-33,5
-35,1
4,7%

-41,6
EPS
 $
Released
Forecast
Spread
-1,05
-1,14
8,1%

-0,97
Announcement Date03/16/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
1,03
0,94
8,9%

0,94
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-10,3
-10,1
-2,5%

-10,9
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-10,7
-10,2
-4,9%

-11,1
Net income
Million $
Released
Forecast
Spread
-10,7
-10,2
-4,9%

-11,1
EPS
 $
Released
Forecast
Spread
-0,26
-0,25
-6,1%

-0,24
Announcement Date11/01/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise